TAYLOR PINNEY: Open Payments
NPI 1629572094 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,063 in 115 payments from 16 companies in 2025. Trend: 2023 $674 · 2024 $1,423 · 2025 $2,063
Food & beverage: $2,063
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $378 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $375 |
| Janssen Biotech, Inc. | 23 | $374 |
| Madrigal Pharmaceuticals | 3 | $179 |
| GENZYME CORPORATION | 6 | $133 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| QOL Medical, LLC | 6 | $103 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| Ardelyx, Inc. | 5 | $90 |
| Gilead Sciences, Inc. | 3 | $65 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, LINZESS, REZDIFFRA, RINVOQ, Sucraid, IBSRELA.
Industry payments across IN — which companies pay providers there.
